Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03861364Phase 4Completed
Phase 4, randomised, double-blind trial of propofol in hemodynamic instability (2 arms), sponsored by Helse Fonna. Primary endpoints: Systolic blood pressure at 7.5 minutes and Heart rate at 7.5 minutes. Started Sep 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03861364.